↓ Skip to main content

CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing

Overview of attention for article published in BMC Cancer, September 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

blogs
1 blog
twitter
7 X users

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
70 Mendeley
Title
CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing
Published in
BMC Cancer, September 2019
DOI 10.1186/s12885-019-6131-1
Pubmed ID
Authors

Lena Andersch, Josefine Radke, Anika Klaus, Silke Schwiebert, Annika Winkler, Elisa Schumann, Laura Grunewald, Felix Zirngibl, Carina Flemmig, Michael C. Jensen, Claudia Rossig, Antonia Joussen, Anton Henssen, Angelika Eggert, Johannes H. Schulte, Annette Künkele

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 70 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 16%
Student > Ph. D. Student 9 13%
Researcher 9 13%
Student > Master 6 9%
Other 4 6%
Other 8 11%
Unknown 23 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 12 17%
Medicine and Dentistry 10 14%
Immunology and Microbiology 7 10%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Agricultural and Biological Sciences 3 4%
Other 8 11%
Unknown 25 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 November 2023.
All research outputs
#2,923,513
of 24,778,793 outputs
Outputs from BMC Cancer
#574
of 8,775 outputs
Outputs of similar age
#57,612
of 346,642 outputs
Outputs of similar age from BMC Cancer
#10
of 159 outputs
Altmetric has tracked 24,778,793 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,775 research outputs from this source. They receive a mean Attention Score of 4.6. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,642 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 159 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.